Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

We can study ultrarare tumors effectively in this day and age, it just takes a cooperative approach: The role of dasatinib in assorted indolent sarcomas.

Villalobos VM, Hoffner B, Elias AD.

Cancer. 2017 Jan 1;123(1):20-24. doi: 10.1002/cncr.30377. Epub 2016 Oct 3. No abstract available.

2.

Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.

Ribas A, Hamid O, Daud A, Hodi FS, Wolchok JD, Kefford R, Joshua AM, Patnaik A, Hwu WJ, Weber JS, Gangadhar TC, Hersey P, Dronca R, Joseph RW, Zarour H, Chmielowski B, Lawrence DP, Algazi A, Rizvi NA, Hoffner B, Mateus C, Gergich K, Lindia JA, Giannotti M, Li XN, Ebbinghaus S, Kang SP, Robert C.

JAMA. 2016 Apr 19;315(15):1600-9. doi: 10.1001/jama.2016.4059. Erratum in: JAMA. 2016 Jun 14;315(22):2472.

PMID:
27092830
3.

Programmed death 1 immune checkpoint inhibitors.

Trivedi MS, Hoffner B, Winkelmann JL, Abbott ME, Hamid O, Carvajal RD.

Clin Adv Hematol Oncol. 2015 Dec;13(12):858-68. Review.

PMID:
27058852
4.

Administration and Handling of Talimogene Laherparepvec: An Intralesional Oncolytic Immunotherapy for Melanoma.

Hoffner B, Iodice GM, Gasal E.

Oncol Nurs Forum. 2016 Mar;43(2):219-26. doi: 10.1188/16.ONF.219-226.

PMID:
26906132
5.

A novel CCAAT/enhancer binding protein α germline variant in a case of acute myeloid leukemia.

Gutman JA, Hoffner B.

Leuk Lymphoma. 2012 May;53(5):1006-7. doi: 10.3109/10428194.2011.638718. Epub 2012 Jan 3. No abstract available.

PMID:
22066712
6.

"Entering a Clinical Trial: Is it Right for You?": a randomized study of The Clinical Trials Video and its impact on the informed consent process.

Hoffner B, Bauer-Wu S, Hitchcock-Bryan S, Powell M, Wolanski A, Joffe S.

Cancer. 2012 Apr 1;118(7):1877-83. doi: 10.1002/cncr.26438. Epub 2011 Aug 25.

7.

A draft sequence of the Neandertal genome.

Green RE, Krause J, Briggs AW, Maricic T, Stenzel U, Kircher M, Patterson N, Li H, Zhai W, Fritz MH, Hansen NF, Durand EY, Malaspinas AS, Jensen JD, Marques-Bonet T, Alkan C, Prüfer K, Meyer M, Burbano HA, Good JM, Schultz R, Aximu-Petri A, Butthof A, Höber B, Höffner B, Siegemund M, Weihmann A, Nusbaum C, Lander ES, Russ C, Novod N, Affourtit J, Egholm M, Verna C, Rudan P, Brajkovic D, Kucan Z, Gusic I, Doronichev VB, Golovanova LV, Lalueza-Fox C, de la Rasilla M, Fortea J, Rosas A, Schmitz RW, Johnson PL, Eichler EE, Falush D, Birney E, Mullikin JC, Slatkin M, Nielsen R, Kelso J, Lachmann M, Reich D, Pääbo S.

Science. 2010 May 7;328(5979):710-22. doi: 10.1126/science.1188021.

8.

Vaccination against the Human Papillomavirus: the lessons we have not learned.

Hoffner B.

Vaccine. 2009 Apr 6;27(16):2195-8. doi: 10.1016/j.vaccine.2008.10.016. Epub 2008 Oct 26.

PMID:
18955099
9.

From micrograms to picograms: quantitative PCR reduces the material demands of high-throughput sequencing.

Meyer M, Briggs AW, Maricic T, Höber B, Höffner B, Krause J, Weihmann A, Pääbo S, Hofreiter M.

Nucleic Acids Res. 2008 Jan;36(1):e5. Epub 2007 Dec 15.

Supplemental Content

Loading ...
Support Center